These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 32577156)

  • 1. Alterations in TGF-β signaling leads to high HMGA2 levels potentially through modulation of PJA1/SMAD3 in HCC cells.
    Ohshiro K; Chen J; Srivastav J; Mishra L; Mishra B
    Genes Cancer; 2020; 11(1-2):43-52. PubMed ID: 32577156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dysregulated PJA1-TGF-β signaling in cancer stem cell-associated liver cancers.
    Chen J; A Gingold J
    Oncoscience; 2020 Nov; 7(11-12):88-95. PubMed ID: 33457451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HMGA2 facilitates epithelial-mesenchymal transition in renal cell carcinoma by regulating the TGF-β/Smad2 signaling pathway.
    Kou B; Liu W; Tang X; Kou Q
    Oncol Rep; 2018 Jan; 39(1):101-108. PubMed ID: 29138866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. OTUB2 Promotes Proliferation and Migration of Hepatocellular Carcinoma Cells by PJA1 Deubiquitylation.
    Hu G; Yang J; Zhang H; Huang Z; Yang H
    Cell Mol Bioeng; 2022 Jun; 15(3):281-292. PubMed ID: 35611163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HEY2 acting as a co-repressor with smad3 and smad4 interferes with the response of TGF-beta in hepatocellular carcinoma.
    Wang J; Zhu B; Zhang Y; Saiyin H; Wumaier R; Yu L; Sun L; Xiao Q
    Am J Transl Res; 2019; 11(7):4367-4381. PubMed ID: 31396342
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mucin1 mediates autocrine transforming growth factor beta signaling through activating the c-Jun N-terminal kinase/activator protein 1 pathway in human hepatocellular carcinoma cells.
    Li Q; Liu G; Shao D; Wang J; Yuan H; Chen T; Zhai R; Ni W; Tai G
    Int J Biochem Cell Biol; 2015 Feb; 59():116-25. PubMed ID: 25526895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heme oxygenase-1/carbon monoxide axis suppresses transforming growth factor-β1-induced growth inhibition by increasing ERK1/2-mediated phosphorylation of Smad3 at Thr-179 in human hepatocellular carcinoma cell lines.
    Park SJ; Lee SK; Lim CR; Park HW; Liu F; Kim SJ; Kim BC
    Biochem Biophys Res Commun; 2018 Apr; 498(3):609-615. PubMed ID: 29524413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Downregulation of hepatocyte nuclear factor-4alpha and its role in regulation of gene expression by TGF-beta in mammary epithelial cells.
    Ishikawa F; Nose K; Shibanuma M
    Exp Cell Res; 2008 Jun; 314(10):2131-40. PubMed ID: 18433744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Compound Astragalus and Salvia miltiorrhiza extract inhibits hepatocellular carcinoma progression via miR-145/miR-21 mediated Smad3 phosphorylation.
    Wu C; Chen W; Fang M; Boye A; Tao X; Xu Y; Hou S; Yang Y
    J Ethnopharmacol; 2019 Mar; 231():98-112. PubMed ID: 30412748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular pathogenesis of hepatocellular carcinoma: altering transforming growth factor-β signaling in hepatocarcinogenesis.
    Yamazaki K; Masugi Y; Sakamoto M
    Dig Dis; 2011; 29(3):284-8. PubMed ID: 21829019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Smad3 and its phosphoisoforms are prognostic predictors of hepatocellular carcinoma after curative hepatectomy.
    Kim SH; Ahn S; Park CK
    Hepatobiliary Pancreat Dis Int; 2012 Feb; 11(1):51-9. PubMed ID: 22251470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic variants of ADAM17 are implicated in the pathological process of Kawasaki disease and secondary coronary artery lesions via the TGF-β/SMAD3 signaling pathway.
    Peng Q; Deng Y; Yang X; Leng X; Yang Y; Liu H
    Eur J Pediatr; 2016 May; 175(5):705-13. PubMed ID: 26833052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic alterations of the TGF-beta signaling pathway in colorectal cancer cell lines: a novel mutation in Smad3 associated with the inactivation of TGF-beta-induced transcriptional activation.
    Ku JL; Park SH; Yoon KA; Shin YK; Kim KH; Choi JS; Kang HC; Kim IJ; Han IO; Park JG
    Cancer Lett; 2007 Mar; 247(2):283-92. PubMed ID: 16828225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Propofol inhibits hepatocellular carcinoma growth and invasion through the HMGA2-mediated Wnt/β-catenin pathway.
    Ou W; Lv J; Zou X; Yao Y; Wu J; Yang J; Wang Z; Ma Y
    Exp Ther Med; 2017 May; 13(5):2501-2506. PubMed ID: 28565871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-9 exerts antitumor effects on hepatocellular carcinoma progression by targeting HMGA2.
    Xu X; Zou H; Luo L; Wang X; Wang G
    FEBS Open Bio; 2019 Oct; 9(10):1784-1797. PubMed ID: 31408273
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CXXC5 suppresses hepatocellular carcinoma by promoting TGF-β-induced cell cycle arrest and apoptosis.
    Yan X; Wu J; Jiang Q; Cheng H; Han JJ; Chen YG
    J Mol Cell Biol; 2018 Feb; 10(1):48-59. PubMed ID: 29036306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-337 regulates the PI3K/AKT and Wnt/β-catenin signaling pathways to inhibit hepatocellular carcinoma progression by targeting high-mobility group AT-hook 2.
    Cui H; Song R; Wu J; Wang W; Chen X; Yin J
    Am J Cancer Res; 2018; 8(3):405-421. PubMed ID: 29636997
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis B virus X protein shifts human hepatic transforming growth factor (TGF)-beta signaling from tumor suppression to oncogenesis in early chronic hepatitis B.
    Murata M; Matsuzaki K; Yoshida K; Sekimoto G; Tahashi Y; Mori S; Uemura Y; Sakaida N; Fujisawa J; Seki T; Kobayashi K; Yokote K; Koike K; Okazaki K
    Hepatology; 2009 Apr; 49(4):1203-17. PubMed ID: 19263472
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of KLF4 and consequential downregulation of Smad7 exacerbate oncogenic TGF-β signaling in and promote progression of hepatocellular carcinoma.
    Sun H; Peng Z; Tang H; Xie D; Jia Z; Zhong L; Zhao S; Ma Z; Gao Y; Zeng L; Luo R; Xie K
    Oncogene; 2017 May; 36(21):2957-2968. PubMed ID: 28192402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of Mesenchymal Stem Cells and Vitamin D on Transforming Growth Factor Beta Signaling Pathway in Hepatocellular Carcinoma in Rats.
    Saad El-Din S; Fouad H; Rashed LA; Mahfouz S; Hussein RE
    Asian Pac J Cancer Prev; 2018 Apr; 19(4):905-912. PubMed ID: 29693337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.